Joint Technology Initiatives

Innovative Medicine initiative 2

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. It is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA supporting collaborative research projects and building networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

IMI launches a number of research and/or training projects every year for which participants are recruited through open and competitive Calls for research proposals, most of the time involving a two-stage process.

More information